- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05819645
Oral Fluid Intake After Extubation
October 17, 2024 updated by: Durila Miroslav MUDr. Ph.D., University Hospital, Motol
Early Versus Delayed Oral Fluid Intake Initiation (Sipping) After Extubation, Influence on the Feeling of Thirst, Patient Comfort and the Occurrence of Complications.
According to the current guidelines the patient is not allowed to drink any fluid at least 2 hours after extubation to prevent complications.
However there is no evidence in the literature to support this approach.
Because anaesthetic drugs and their side effects changed significantly from their first usage, the investigators can assume that existing approach is obsolete and has no place anymore in the modern medicine.
Keeping patient n.p.o (nothing per os) for 2 hours after extubation may lead to patient´s thirst or other discomfort.
The aim of the study is to detect whether early oral fluid intake after extubation could lead to safe relief of thirst and to better patient´s comfort overall.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Everything stated in the brief summary.
Study Type
Interventional
Enrollment (Actual)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Czech Republic
-
Prague, Czech Republic, Czechia, 15006
- University Hospital Motol, Charles University in Prague
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- patients with planned extubation assigned to the study
- able to swallow the fluid
- willing to participate the study
Exclusion Criteria:
- patients after upper digestive tract surgery
- patients after trachea surgery
- patients with possible neurological deficiency
- patients after VIII. cranial nerve surgery
- patients not able to swallow
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Early fluid intake
|
The participant will be randomized into two arms.
After the randomization one arm will get the per os fluid intake before the standard time frame.
|
|
Other: Standard Delayed oral fluid
|
The participant will be randomized into two arms.
After the randomization one arm will get the per os fluid intake before the standard time frame.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of presence or absence of thirst 120 minutes after extubation
Time Frame: During procedure (120 minutes after extubation)
|
Between both groups the presence of anpleasent feeling of thirst will be assessed and compared
|
During procedure (120 minutes after extubation)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Actual)
October 16, 2024
Study Completion (Actual)
October 16, 2024
Study Registration Dates
First Submitted
January 6, 2023
First Submitted That Met QC Criteria
April 15, 2023
First Posted (Actual)
April 19, 2023
Study Record Updates
Last Update Posted (Actual)
October 21, 2024
Last Update Submitted That Met QC Criteria
October 17, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- EK-1381/22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intubation
-
National Cheng-Kung University HospitalNot yet recruitingIntubation; Complication | Intubation Intraesophageal | Intubation Depth | Intubation, Nasogastric | Intubation Times
-
Kanuni Sultan Suleyman Training and Research HospitalRecruitingIntubation | Intubation, Endotracheal | Intubation Complications | Rapid Sequence Induction and Intubation | Delayed Sequence IntubationTurkey (Türkiye)
-
Spanish Network for Research in Infectious DiseasesCompletedIntubation | Intubation Complication | Intubation; Difficult or FailedSpain
-
University Hospital, Clermont-FerrandSociété Française d'Anesthésie-Réanimation (SFAR)CompletedEndotracheal Intubation | Intubation Complication | Intubation; Difficult or FailedFrance
-
Emory UniversityTerminatedAirway Morbidity | Intubation Complication | Anesthesia Intubation Complication | Tracheal Intubation Morbidity | Failed or Difficult Intubation, SequelaUnited States
-
Catharina Ziekenhuis EindhovenCompletedAnesthesia Intubation Complication | Intubation; Difficult | Failed or Difficult Intubation | Failed or Difficult Intubation, Initial EncounterNetherlands
-
NHS LothianMedtronicNot yet recruitingIntubation Complications | Intubation Skill | Intubation With Uncuffed Endotracheal TubeUnited Kingdom
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntubation Complication | Intubation;Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Singapore
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)RecruitingIntubation Complication | Intubation; Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Japan, New Zealand, Singapore, Australia, Austria, India, United Kingdom, Italy, Germany
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedIntubation, Nasotracheal IntubationTaiwan
Clinical Trials on Fluid intake not as per standard guidlines
-
iOMEDICO AGRecruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction AdenocarcinomaGermany
-
iOMEDICO AGDeutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
iOMEDICO AGRecruitingChronic Lymphocytic Leukemia (CLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL) | Waldenström's Macroglobulinemia (WM)Germany
-
iOMEDICO AGRecruiting
-
The Rotunda HospitalCompletedElective Cesarean Delivery | Fasting ( 6H for Solid ; 2H for Clear Fluid )Ireland
-
University Health Network, TorontoActive, not recruitingHigh Grade GliomaCanada
-
Société des Produits Nestlé (SPN)Chulalongkorn UniversityCompletedInfant NutritionThailand
-
Sindh Institute of Urology and TransplantationRecruitingPatient Satisfaction | Thirst; Due to Deprivation of WaterPakistan
-
Children's Hospital Medical Center, CincinnatiRecruitingLymphoma | Follicular Lymphoma | Leukemia | B Cell Lymphoma | Hodgkin Lymphoma | Burkitt Lymphoma | AML | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Diffuse Large B Cell Lymphoma | Hematologic Malignancy | Chronic Myelogenous Leukemia | Myeloproliferative Neoplasm | T-cell Lymphoma | Peripheral T Cell Lymphoma and other conditionsUnited States
-
The University of Texas Health Science Center,...Withdrawn